Gilead Sciences, Inc.
Long

GILEAD BUY

327
Gilead is giving a re entry point here.

AT:
Price its un compressing , has break the trendLine giving us a good RR entry.

Fundamentals:
July 22 is the earning report ,the US government has purchased all available stock of the remdesivir vaccine.

Enjoy profits , and don't forget to follow us for more ! :D

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.